RARRES2 and breast cancer: Additionally, we then examined the expression of RARRES2 using the MetMap data (GSE148283) and found a significant downregulation of RARRES2 in the breast cancer cells metastasized to the brain compared to metastasis in the liver (P = 0.0003, Fig. 1g).